Israeli blood cancer treatment could also kill solid tumors - new study
Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.
Tel Aviv University researchers (from left): Dr. Yaron Carmi, Diana Rasuluniriana, Dr. Peleg Ride(photo credit: TEL AVIV UNIVERSITY)